Management of thrombophilia.

Abstract excerpt

It is now possible to identify acquired and hereditary risk factors in a substantial percentage of patients presenting with a venous thrombotic event. Discovery of the factor V Leiden and prothrombin G20210A mutations has greatly increased the percentage of patients in whom venous thrombosis can be attributed to hereditary thrombophilia. There is, however, considerable uncertainty as to how this information...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Anticoagulants
• Share to Factor V
• Share to Pregnancy